Literature DB >> 11110689

Zebrafish homolog of the leukemia gene CBFB: its expression during embryogenesis and its relationship to scl and gata-1 in hematopoiesis.

T Blake1, N Adya, C H Kim, A C Oates, L Zon, A Chitnis, B M Weinstein, P P Liu.   

Abstract

Mammalian CBFB encodes a transcription factor (CBF beta) that in combination with CBF alpha 2 binds to specific DNA sequences and regulates expression of a number of hematopoietic genes. CBFB is associated with human leukemias through a chromosome 16 inversion and is essential for definitive hematopoiesis during mouse embryo development. We have isolated a zebrafish cbfb complementary DNA (cDNA) clone from a zebrafish kidney cDNA library. This cbfb is highly homologous to human and mouse CBFB/Cbfb genes at both the DNA and protein level. In biochemical analyses, cbfbeta binds to human CBF alpha 2 and enhances its DNA binding. During zebrafish development, cbfb is expressed in the lateral plate mesoderm at tail bud stage and in the intermediate cell mass (ICM, the location of embryonic hematopoiesis) between the 21- to 26-somite stages. The cbfb is also expressed in Rohon-Beard cells, cranial nerve ganglia, hindbrain, retina, branchial arches, jaw, and fin buds. Expression of cbfb is decreased or absent in the ICM and Rohon-Beard cells in some hematopoietic mutants and is unaffected in others. We have also analyzed the expression of scl and gata-1 in the same hematopoietic mutants to ascertain the relative order of these transcription factors to cbfb in zebrafish hematopoiesis. Our results indicate that cbfb is expressed in early hematopoietic progenitors and that its expression pattern in the hematopoietic mutants is similar to that of scl. (Blood. 2000;96:4178-4184)

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11110689

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  8 in total

1.  CBFβ and RUNX1 are required at 2 different steps during the development of hematopoietic stem cells in zebrafish.

Authors:  Erica Bresciani; Blake Carrington; Stephen Wincovitch; MaryPat Jones; Aniket V Gore; Brant M Weinstein; Raman Sood; P Paul Liu
Journal:  Blood       Date:  2014-05-21       Impact factor: 22.113

2.  A CCAAT/enhancer binding protein beta isoform, liver-enriched inhibitory protein, regulates commitment of osteoblasts and adipocytes.

Authors:  Kenji Hata; Riko Nishimura; Mio Ueda; Fumiyo Ikeda; Takuma Matsubara; Fumitaka Ichida; Kunihiro Hisada; Takashi Nokubi; Akira Yamaguchi; Toshiyuki Yoneda
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

3.  Crucial role of phosphatidylinositol 4-kinase IIIalpha in development of zebrafish pectoral fin is linked to phosphoinositide 3-kinase and FGF signaling.

Authors:  Hui Ma; Trevor Blake; Ajay Chitnis; Paul Liu; Tamas Balla
Journal:  J Cell Sci       Date:  2009-11-03       Impact factor: 5.285

Review 4.  The zebrafish: A fintastic model for hematopoietic development and disease.

Authors:  Aniket V Gore; Laura M Pillay; Marina Venero Galanternik; Brant M Weinstein
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2018-02-13       Impact factor: 5.814

5.  Incomplete splicing, cell division defects, and hematopoietic blockage in dhx8 mutant zebrafish.

Authors:  Milton A English; Lin Lei; Trevor Blake; Stephen M Wincovitch; Raman Sood; Mizuki Azuma; Dennis Hickstein; P Paul Liu
Journal:  Dev Dyn       Date:  2012-03-29       Impact factor: 3.780

6.  A nonsense mutation in zebrafish gata1 causes the bloodless phenotype in vlad tepes.

Authors:  Susan E Lyons; Nathan D Lawson; Lin Lei; Paul E Bennett; Brant M Weinstein; P Paul Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

Review 7.  The state of the art of the zebrafish model for toxicology and toxicologic pathology research--advantages and current limitations.

Authors:  Jan M Spitsbergen; Michael L Kent
Journal:  Toxicol Pathol       Date:  2003 Jan-Feb       Impact factor: 1.902

Review 8.  RUNX1-ETO: Attacking the Epigenome for Genomic Instable Leukemia.

Authors:  Emiel van der Kouwe; Philipp Bernhard Staber
Journal:  Int J Mol Sci       Date:  2019-01-16       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.